Notably, Tsk2/+ mice have detectable levels of anti-Topo-I autoantibodies (Gentiletti et al., 2005), which are the most frequently observed autoantibodies in SSc patients that have developed pulmonary fibrosis and cardiac complications (Hesselstrand et al., 2003). Here, TSSK2 is linked to systemic sclerosis.